PMV Pharmaceuticals Ownership 2024 | Who Owns PMV Pharmaceuticals Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

83.08%

Insider Ownership

2.61%

Retail Ownership

14.31%

Institutional Holders

100.00

PMV Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ORBIMED ADVISORS LLC12.59%0.20%6,475,291--11,007,995Mar 31, 2024
ARROWMARK COLORADO HOLDINGS LLC6.22%0.06%3,198,756484,61317.86%5,437,885Mar 31, 2024
BLACKROCK INC.6.05%0.00%3,110,309-119,488-3.70%5,287,525Mar 31, 2024
EUCLIDEAN CAPITAL LLC5.11%0.57%2,627,643--4,466,993Mar 31, 2024
VANGUARD GROUP INC4.77%0.00%2,452,11146,8041.95%4,168,589Mar 31, 2024
ALKEON CAPITAL MANAGEMENT LLC4.56%0.01%2,345,361--3,987,113Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC4.04%0.01%2,080,1941,311,745170.70%3,533,000Mar 31, 2024
CITADEL ADVISORS LLC3.07%0.00%1,580,550350,20028.46%2,686,935Mar 31, 2024
BANK OF AMERICA CORP /DE/2.66%0.00%1,367,915-71,926-5.00%2,325,455,000Mar 31, 2024
BML CAPITAL MANAGEMENT, LLC2.54%1.46%1,306,4901,306,490100.00%2,221,033Mar 31, 2024
PFM HEALTH SCIENCES, LP2.48%0.10%1,275,462-197,551-13.41%2,168,285Mar 31, 2024
GOLDMAN SACHS GROUP INC2.13%0.00%1,095,250292,37536.42%1,861,925Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC1.76%0.00%903,13742,8014.97%1,535,498Mar 31, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC1.61%0.01%826,704397,06292.42%1,405,397Mar 31, 2024
STATE STREET CORP1.53%0.00%785,99062,5368.64%1,336,183Mar 31, 2024
D. E. SHAW & CO., INC.1.40%0.00%720,635472,130189.99%1,225,079Mar 31, 2024
GHOST TREE CAPITAL, LLC1.31%0.32%675,000-50,000-6.90%1,147,500Mar 31, 2024
MILLENNIUM MANAGEMENT LLC1.27%0.00%655,461655,461100.00%1,114,284Mar 31, 2024
ECOR1 CAPITAL, LLC1.10%0.02%566,879--963,694Mar 31, 2024
PERSONAL CFO SOLUTIONS, LLC1.07%0.15%550,342--935,581Mar 31, 2024

PMV Pharmaceuticals's largest institutional shareholder is ORBIMED ADVISORS LLC, holding 12.59% of the company's total share outstanding, currently valued at $11.01M. The top 10 institutional shareholders own together 51.60% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BML CAPITAL MANAGEMENT, LLC2.54%1.46%1,306,4901,306,490100.00%2,221,033Mar 31, 2024
EUCLIDEAN CAPITAL LLC5.11%0.57%2,627,643--4,466,993Mar 31, 2024
GHOST TREE CAPITAL, LLC1.31%0.32%675,000-50,000-6.90%1,147,500Mar 31, 2024
ACUITAS INVESTMENTS, LLC0.68%0.30%351,875351,875100.00%598,188Mar 31, 2024
ORBIMED ADVISORS LLC12.59%0.20%6,475,291--11,007,995Mar 31, 2024
OPALEYE MANAGEMENT INC.0.92%0.18%471,481471,481100.00%802,130Mar 31, 2024
PERSONAL CFO SOLUTIONS, LLC1.07%0.15%550,342--935,581Mar 31, 2024
PFM HEALTH SCIENCES, LP2.48%0.10%1,275,462-197,551-13.41%2,168,285Mar 31, 2024
ARROWMARK COLORADO HOLDINGS LLC6.22%0.06%3,198,756484,61317.86%5,437,885Mar 31, 2024
SHAY CAPITAL LLC0.38%0.05%197,178197,178100.00%335,203Mar 31, 2024
XTX TOPCO LTD0.38%0.04%195,006-54,406-21.81%331,510Mar 31, 2024
ECOR1 CAPITAL, LLC1.10%0.02%566,879--963,694Mar 31, 2024
MARQUETTE ASSET MANAGEMENT, LLC0.12%0.02%64,00964,009100.00%108,816Mar 31, 2024
STATE OF WYOMING0.11%0.02%58,08941,291245.81%98,751Mar 31, 2024
FISHMAN JAY A LTD/MI0.16%0.01%80,00050,000166.67%136,000Mar 31, 2024
ATOM INVESTORS LP0.11%0.01%58,24917,18441.85%99,023Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC4.04%0.01%2,080,1941,311,745170.70%3,533,000Mar 31, 2024
HARBOURVEST PARTNERS LLC0.02%0.01%11,533--19,606Mar 31, 2024
UBS OCONNOR LLC0.11%0.01%56,852-69,148-54.88%96,648Mar 31, 2024
BAKER BROS. ADVISORS LP0.63%0.01%322,024--547,441Mar 31, 2024

The largest PMV Pharmaceuticals shareholder by % of total assets is BML CAPITAL MANAGEMENT, LLC. The company owns 1.31M shares of PMV Pharmaceuticals (PMVP), representing 1.46% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ACADIAN ASSET MANAGEMENT LLC4.04%0.01%2,080,1941,311,745170.70%3,533,000Mar 31, 2024
BML CAPITAL MANAGEMENT, LLC2.54%1.46%1,306,4901,306,490100.00%2,221,033Mar 31, 2024
MILLENNIUM MANAGEMENT LLC1.27%0.00%655,461655,461100.00%1,114,284Mar 31, 2024
ARROWMARK COLORADO HOLDINGS LLC6.22%0.06%3,198,756484,61317.86%5,437,885Mar 31, 2024
D. E. SHAW & CO., INC.1.40%0.00%720,635472,130189.99%1,225,079Mar 31, 2024
OPALEYE MANAGEMENT INC.0.92%0.18%471,481471,481100.00%802,130Mar 31, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC1.61%0.01%826,704397,06292.42%1,405,397Mar 31, 2024
ACUITAS INVESTMENTS, LLC0.68%0.30%351,875351,875100.00%598,188Mar 31, 2024
CITADEL ADVISORS LLC3.07%0.00%1,580,550350,20028.46%2,686,935Mar 31, 2024
GOLDMAN SACHS GROUP INC2.13%0.00%1,095,250292,37536.42%1,861,925Mar 31, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.84%0.00%433,853248,730134.36%737,550Mar 31, 2024
SHAY CAPITAL LLC0.38%0.05%197,178197,178100.00%335,203Mar 31, 2024
TWO SIGMA ADVISERS, LP0.71%0.00%365,400176,80093.74%621,180Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.30%-152,391152,391100.00%259,065Mar 31, 2024
MARSHALL WACE, LLP0.26%0.00%131,845131,845100.00%224,137Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.78%0.00%399,710121,00943.42%679,507Mar 31, 2024
MAN GROUP PLC0.22%0.00%114,432114,432100.00%194,534Mar 31, 2024
MARQUETTE ASSET MANAGEMENT, LLC0.12%0.02%64,00964,009100.00%108,816Mar 31, 2024
STATE STREET CORP1.53%0.00%785,99062,5368.64%1,336,183Mar 31, 2024
M&T BANK CORP0.50%0.00%258,48460,80230.76%439,711Mar 31, 2024

As of Mar 31 2024, PMV Pharmaceuticals's largest institutional buyer is ACADIAN ASSET MANAGEMENT LLC. The company purchased 1.31M stocks of PMVP, valued at $3.53M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO0.23%-119,269-3,811,071-96.97%202,757Mar 31, 2024
WOODLINE PARTNERS LP----1,791,553-100.00%-Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.39%0.00%200,938-1,379,549-87.29%341,595Mar 31, 2024
FEDERATED HERMES, INC.0.01%-3,624-699,714-99.48%6,161Mar 31, 2024
SECTORAL ASSET MANAGEMENT INC----685,985-100.00%-Mar 31, 2024
VONTOBEL HOLDING LTD.----685,985-100.00%-Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC----550,000-100.00%-Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.0.40%0.00%205,855-544,298-72.56%349,954Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP0.53%0.00%272,859-284,612-51.05%463,861Mar 31, 2024
PFM HEALTH SCIENCES, LP2.48%0.10%1,275,462-197,551-13.41%2,168,285Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.15%0.00%75,000-119,900-61.52%127,500Mar 31, 2024
BLACKROCK INC.6.05%0.00%3,110,309-119,488-3.70%5,287,525Mar 31, 2024
MOORE CAPITAL MANAGEMENT, LP----104,000-100.00%-Mar 31, 2024
AMERIPRISE FINANCIAL INC0.10%-49,794-75,586-60.29%84,650Mar 31, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----72,683-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/2.66%0.00%1,367,915-71,926-5.00%2,325,455,000Mar 31, 2024
UBS OCONNOR LLC0.11%0.01%56,852-69,148-54.88%96,648Mar 31, 2024
XTX TOPCO LTD0.38%0.04%195,006-54,406-21.81%331,510Mar 31, 2024
GHOST TREE CAPITAL, LLC1.31%0.32%675,000-50,000-6.90%1,147,500Mar 31, 2024
AQR CAPITAL MANAGEMENT LLC0.22%0.00%114,975-42,670-27.07%195,458Mar 31, 2024

As of Mar 31 2024, PMV Pharmaceuticals's biggest institutional seller is JPMORGAN CHASE & CO. The company sold -3.81M shares of PMVP, valued at $202.76K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BML CAPITAL MANAGEMENT, LLC2.54%1.46%1,306,4901,306,490100.00%2,221,033Mar 31, 2024
OPALEYE MANAGEMENT INC.0.92%0.18%471,481471,481100.00%802,130Mar 31, 2024
ACUITAS INVESTMENTS, LLC0.68%0.30%351,875351,875100.00%598,188Mar 31, 2024
SHAY CAPITAL LLC0.38%0.05%197,178197,178100.00%335,203Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.30%-152,391152,391100.00%259,065Mar 31, 2024
MAN GROUP PLC0.22%0.00%114,432114,432100.00%194,534Mar 31, 2024
MARQUETTE ASSET MANAGEMENT, LLC0.12%0.02%64,00964,009100.00%108,816Mar 31, 2024
PANAGORA ASSET MANAGEMENT INC0.04%0.00%18,70518,705100.00%31,799Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.02%0.00%10,00010,000100.00%17,000Mar 31, 2024
AVION WEALTH0.00%0.00%299299100.00%1,000Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--88100.00%13Mar 31, 2024

PMV Pharmaceuticals's largest new institutional shareholder by number of shares is BML CAPITAL MANAGEMENT, LLC, purchased 1.31M shares, valued at $2.22M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WOODLINE PARTNERS LP----1,791,553-100.00%-Mar 31, 2024
SECTORAL ASSET MANAGEMENT INC----685,985-100.00%-Mar 31, 2024
VONTOBEL HOLDING LTD.----685,985-100.00%-Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC----550,000-100.00%-Mar 31, 2024
MOORE CAPITAL MANAGEMENT, LP----104,000-100.00%-Mar 31, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----72,683-100.00%-Mar 31, 2024
DENALI ADVISORS LLC----33,900-100.00%-Mar 31, 2024
ARISTIDES CAPITAL LLC----31,145-100.00%-Mar 31, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.----22,915-100.00%-Mar 31, 2024
SG AMERICAS SECURITIES, LLC----20,994-100.00%-Mar 31, 2024
SCIENTECH RESEARCH LLC----11,322-100.00%-Mar 31, 2024
CAPTION MANAGEMENT, LLC----11,221-100.00%-Mar 31, 2024
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM----11,134-100.00%-Mar 31, 2024
NEWEDGE ADVISORS, LLC----31-100.00%-Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.----15-100.00%-Mar 31, 2024

PMV Pharmaceuticals's largest sold out institutional shareholder by shares sold is WOODLINE PARTNERS LP, sold -1.79M shares, valued at -, as of undefined.

PMV Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
MERIDIAN FUND INC0.34%1,203,968883,654275.87%Dec 29, 2023
Federated Hermes MDT Series0.27%655,744-106,040-13.92%Jan 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.19%36,039--Dec 29, 2023
PRUDENTIAL SECTOR FUNDS, INC.0.17%348,786--Feb 29, 2024
BlackRock Health Sciences Trust II0.11%305,830--Dec 31, 2023
Advantage Advisers Xanthus Fund, L.L.C.0.11%329,949--Mar 31, 2024
ACAP Strategic Fund0.08%1,147,095--Dec 31, 2023
BRIDGEWAY FUNDS INC0.08%194,90099,900105.16%Dec 29, 2023
VANGUARD VALLEY FORGE FUNDS0.08%37,924--Dec 31, 2023
ALGER FUNDS0.06%60,414--Jan 31, 2024
Humankind Benefit Corp0.06%1,288--Dec 31, 2023
VICTORY VARIABLE INSURANCE FUNDS0.05%24,940--Dec 31, 2023
BlackRock Health Sciences Trust0.04%17,490--Dec 31, 2023
IndexIQ ETF Trust0.03%67,951-4,909-6.74%Jan 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.02%96,760--Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%5,590--Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.01%772,700--Feb 29, 2024
ETFis Series Trust I0.01%16,534--Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%67,477--Dec 31, 2023
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.01%25,897-8,115-23.86%Dec 31, 2023
T. Rowe Price Equity Series, Inc.0.01%9,900--Dec 31, 2023
VANGUARD INDEX FUNDS0.01%2,588,779877,92251.31%Dec 31, 2023
UBS FUNDS0.00%23,641--Dec 31, 2023
FIDELITY MT VERNON STREET TRUST0.00%129,095--Feb 29, 2024
FIDELITY COMMONWEALTH TRUST0.00%12,708--Feb 29, 2024
DRIEHAUS MUTUAL FUNDS0.00%31,933--Dec 29, 2023
TIAA SEPARATE ACCOUNT VA 10.00%754--Dec 31, 2023
NEW COVENANT FUNDS0.00%12,323--Dec 31, 2023
ALPS ETF Trust0.00%28,833--Feb 29, 2024
JPMORGAN INSURANCE TRUST0.00%24,416-1,084-4.25%Mar 31, 2023
Nushares ETF Trust0.00%13,156--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%377,33550,65615.51%Feb 29, 2024
Calvert Variable Products, Inc.0.00%3,772--Dec 31, 2023
TARGET PORTFOLIO TRUST0.00%31,000--Jan 31, 2024
Direxion Shares ETF Trust0.00%207,390--Jan 31, 2024
JPMORGAN TRUST II0.00%1,172,588--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%18,518--Feb 29, 2024
VICTORY PORTFOLIOS0.00%31,410--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%29,279--Dec 31, 2023
SCHWAB STRATEGIC TRUST0.00%175,5206,5253.86%Feb 29, 2024
BlackRock ETF Trust0.00%723--Jan 31, 2024
PRINCIPAL VARIABLE CONTRACTS FUNDS INC0.00%32,400--Dec 31, 2023
Principal Exchange-Traded Funds0.00%9,331-1,436-13.34%Mar 31, 2024
JOHN HANCOCK INVESTMENT TRUST0.00%53,985--Jan 31, 2024
VALIC Co I0.00%168,769-60-0.04%Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%16,882--Dec 31, 2023
Voya INVESTORS TRUST0.00%27,748--Dec 31, 2023
NATIONWIDE VARIABLE INSURANCE TRUST0.00%70,11827,46464.39%Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%2,176--Dec 31, 2023
AMERICAN CENTURY ETF TRUST0.00%47,49912,15734.40%Feb 29, 2024
VANGUARD WORLD FUND0.00%99,15013,79216.16%Feb 29, 2024
SEASONS SERIES TRUST0.00%8,851--Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%343,953-9,219-2.61%Jan 31, 2024
SA FUNDS INVESTMENT TRUST0.00%3,331--Dec 31, 2023
Dimensional ETF Trust0.00%79,224-32,748-29.25%Jan 31, 2024
Goldman Sachs ETF Trust0.00%17,627--Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%437--Dec 31, 2023
MASTER INVESTMENT PORTFOLIO0.00%13,504--Dec 31, 2023
Trust for Advised Portfolios0.00%3,076--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,922-772-28.66%Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%11,100--Dec 31, 2023
EQ ADVISORS TRUST0.00%122,1771,4101.17%Dec 31, 2023
iSHARES TRUST0.00%1,478,976--Feb 29, 2024
THRIVENT SERIES FUND INC0.00%9,352--Dec 29, 2023
RYDEX SERIES FUNDS0.00%352--Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%167,78819,41913.09%Feb 29, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%223,750200,230851.32%Dec 31, 2023
SPDR SERIES TRUST0.00%2,558,483--Dec 31, 2023
RBB FUND, INC.0.00%6,208--Feb 29, 2024
ProFunds0.00%55022669.75%Jan 31, 2024
PENN SERIES FUNDS INC0.00%1,400--Dec 29, 2023
NATIONWIDE MUTUAL FUNDS0.00%5,8871,45232.74%Jan 31, 2024
RYDEX DYNAMIC FUNDS0.00%174--Dec 31, 2023
BLACKROCK FUNDS0.00%280,445-17,392-5.84%Feb 29, 2024
ALLSPRING MASTER TRUST0.00%2,482--Feb 29, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%1,808--Dec 31, 2023
COLUMBIA FUNDS SERIES TRUST I0.00%138,96518,44615.31%Feb 29, 2024
NORTHERN FUNDS0.00%25,221--Dec 29, 2023
Guggenheim Active Allocation Fund0.00%156--Feb 29, 2024
PROSHARES TRUST0.00%5,649-2,432-30.10%Feb 29, 2024
HC CAPITAL TRUST0.00%664--Dec 31, 2023
RYDEX VARIABLE TRUST0.00%23--Dec 31, 2023
Blackstone Alternative Investment Funds0.00%2,4001,500166.67%Dec 31, 2023
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%38,743-20,852-34.99%Dec 31, 2023
Franklin Alternative Strategies Funds0.00%9,168--Feb 29, 2024
PGIM ETF TRUST0.00%833--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%4,369-18-0.41%Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,268--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%14,315--Dec 31, 2023
Brinker Capital Destinations Trust0.00%702--Feb 29, 2024
Advisors' Inner Circle Fund III0.00%1396178.21%Jan 31, 2024
ADVANCED SERIES TRUST0.00%30,884--Dec 29, 2023
AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS)0.00%16,500--Dec 31, 2023
Brighthouse Funds Trust II0.00%13,301--Dec 31, 2023
PACIFIC SELECT FUND0.00%15,134-15,397-50.43%Dec 31, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%7,101-9,758-57.88%Dec 31, 2023
Goldman Sachs Trust II0.00%18,130--Jan 31, 2024
SPDR INDEX SHARES FUNDS0.00%508--Dec 31, 2023
Bridge Builder Trust0.00%15,929--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%2,068--Dec 31, 2023

PMV Pharmaceuticals's largest mutual fund holder by % of total assets is "MERIDIAN FUND INC", owning 1.20M shares, compromising 0.34% of its total assets.

PMV Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24100-
31 Dec, 23100-8.26%
30 Sep, 231091.87%
30 Jun, 23107-5.31%
31 Mar, 23113-3.42%
31 Dec, 22117-1.68%
30 Sep, 221196.25%
30 Jun, 22112-
31 Mar, 2211210.89%
31 Dec, 2110112.22%
30 Sep, 21905.88%
30 Jun, 21853.66%
31 Mar, 218212.33%
31 Dec, 207343.14%
30 Sep, 2051-

As of 31 Mar 24, 100 institutions are holding PMV Pharmaceuticals's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2442,741,191-7.98%
31 Dec, 2346,445,206-14.13%
30 Sep, 2354,086,1644.82%
30 Jun, 2351,598,0410.83%
31 Mar, 2351,172,466-6.04%
31 Dec, 2254,459,134-6.22%
30 Sep, 2258,070,322-4.94%
30 Jun, 2261,091,04610.66%
31 Mar, 2255,207,02316.50%
31 Dec, 2147,388,4977.82%
30 Sep, 2143,949,4734.04%
30 Jun, 2142,243,0805.83%
31 Mar, 2139,916,4544.45%
31 Dec, 2038,214,22222.43%
30 Sep, 2031,212,908-

PMV Pharmaceuticals (PMVP) has 42.74M shares outstanding as of 31 Mar 24, down -7.98% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2483.08%0.93%
31 Dec, 2394.69%0.68%
30 Sep, 23118.06%0.93%
30 Jun, 23112.73%0.90%
31 Mar, 23111.80%0.77%
31 Dec, 22120.23%0.74%
30 Sep, 22127.28%0.71%
30 Jun, 22134.06%0.91%
31 Mar, 22121.42%1.11%
31 Dec, 21104.62%1.11%
30 Sep, 2197.03%1.10%
30 Jun, 2193.73%1.18%
31 Mar, 2189.13%1.22%
31 Dec, 2085.33%1.76%
30 Sep, 2069.69%-

As of 31 Mar 24, PMV Pharmaceuticals is held by 83.08% institutional shareholders, representing a 0.93% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2450-13.79%
31 Dec, 235820.83%
30 Sep, 2348-17.24%
30 Jun, 2358-
31 Mar, 235818.37%
31 Dec, 2249-25.76%
30 Sep, 2266-14.29%
30 Jun, 227740.00%
31 Mar, 2255-12.70%
31 Dec, 216336.96%
30 Sep, 2146-22.03%
30 Jun, 215922.92%
31 Mar, 2148-12.73%
31 Dec, 20557.84%
30 Sep, 2051-

50 institutional shareholders have increased their position in PMVP stock as of 31 Mar 24 compared to 58 in the previous quarter (a -13.79% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2426-10.34%
31 Dec, 2329-14.71%
30 Sep, 233421.43%
30 Jun, 2328-20.00%
31 Mar, 2335-7.89%
31 Dec, 223822.58%
30 Sep, 223182.35%
30 Jun, 2217-41.38%
31 Mar, 222931.82%
31 Dec, 2122-18.52%
30 Sep, 212792.86%
30 Jun, 2114-30.00%
31 Mar, 212081.82%
31 Dec, 2011-
30 Sep, 20--

26 institutional shareholders have reduced their position in PMVP stock as of 31 Mar 24 compared to 29 in the previous quarter (a -10.34% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24100-42,741,191-7.98%83.08%0.93%50-13.79%26-10.34%
31 Dec, 23100-8.26%46,445,206-14.13%94.69%0.68%5820.83%29-14.71%
30 Sep, 231091.87%54,086,1644.82%118.06%0.93%48-17.24%3421.43%
30 Jun, 23107-5.31%51,598,0410.83%112.73%0.90%58-28-20.00%
31 Mar, 23113-3.42%51,172,466-6.04%111.80%0.77%5818.37%35-7.89%
31 Dec, 22117-1.68%54,459,134-6.22%120.23%0.74%49-25.76%3822.58%
30 Sep, 221196.25%58,070,322-4.94%127.28%0.71%66-14.29%3182.35%
30 Jun, 22112-61,091,04610.66%134.06%0.91%7740.00%17-41.38%
31 Mar, 2211210.89%55,207,02316.50%121.42%1.11%55-12.70%2931.82%
31 Dec, 2110112.22%47,388,4977.82%104.62%1.11%6336.96%22-18.52%
30 Sep, 21905.88%43,949,4734.04%97.03%1.10%46-22.03%2792.86%
30 Jun, 21853.66%42,243,0805.83%93.73%1.18%5922.92%14-30.00%
31 Mar, 218212.33%39,916,4544.45%89.13%1.22%48-12.73%2081.82%
31 Dec, 207343.14%38,214,22222.43%85.33%1.76%557.84%11-
30 Sep, 2051-31,212,908-69.69%-51---

PMV Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 24, 2023ORBIMED ADVISORS LLC10 percent owner-S-SaleSell87,786$2.23$195.76K-
Sep 18, 2023Jalota Deepikaofficer Chief Development OfficerS-SaleSell4,104$6.62$27.17K29,946
Sep 18, 2023Alland Leilaofficer Chief Medical OfficerS-SaleSell6,291$6.62$41.65K45,909

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 11, 2024Carulli Michaelofficer Chief Financial OfficerSell---9,066
Jan 11, 2024Carulli Michaelofficer Chief Financial OfficerSell13,605$28.33$385.43K-
Jan 11, 2024Carulli Michaelofficer Chief Financial OfficerSell24,632$4.22$103.95K-
Jan 11, 2024Carulli Michaelofficer Chief Financial OfficerSell27,200$16.29$443.09K-
Jan 11, 2024Carulli Michaelofficer Chief Financial OfficerSell75,000$5.70$427.50K-
Nov 24, 2023ORBIMED ADVISORS LLC10 percent owner-S-SaleSell87,786$2.23$195.76K-
Nov 13, 2023Mack David Henrydirector, officer President and CEOG-GiftSell85,307--278,570
Nov 13, 2023Mack David Henrydirector, officer President and CEOM-ExemptSell198,407$0.53$105.16K109,459
Sep 18, 2023Jalota Deepikaofficer Chief Development OfficerS-SaleSell4,104$6.62$27.17K29,946
Sep 18, 2023Alland Leilaofficer Chief Medical OfficerS-SaleSell6,291$6.62$41.65K45,909
Aug 08, 2023Mack David Henrydirector, officer President and CEOM-ExemptSell85,500$0.53$45.31K307,866

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 22, 2024Jalota Deepikaofficer Chief Development OfficerA-AwardBuy225,095$1.80$405.17K225,095
Jan 22, 2024Jalota Deepikaofficer Chief Development OfficerA-AwardBuy95,555--125,501
Jan 22, 2024Carulli Michaelofficer Chief Financial OfficerA-AwardBuy204,630$1.80$368.33K204,630
Jan 22, 2024Carulli Michaelofficer Chief Financial OfficerA-AwardBuy82,220--91,286
Jan 22, 2024Mack David Henrydirector, officer President and CEOA-AwardBuy519,915$1.80$935.85K519,915
Jan 22, 2024Mack David Henrydirector, officer President and CEOA-AwardBuy163,890--442,460
Jan 11, 2024Carulli Michaelofficer Chief Financial OfficerSell---9,066
Jan 11, 2024Carulli Michaelofficer Chief Financial OfficerSell13,605$28.33$385.43K-
Jan 11, 2024Carulli Michaelofficer Chief Financial OfficerSell24,632$4.22$103.95K-
Jan 11, 2024Carulli Michaelofficer Chief Financial OfficerSell27,200$16.29$443.09K-
Jan 11, 2024Carulli Michaelofficer Chief Financial OfficerSell75,000$5.70$427.50K-
Nov 24, 2023ORBIMED ADVISORS LLC10 percent owner-S-SaleSell87,786$2.23$195.76K-
Nov 13, 2023Mack David Henrydirector, officer President and CEOM-ExemptBuy198,407$0.53$105.16K363,877
Nov 13, 2023Mack David Henrydirector, officer President and CEOG-GiftSell85,307--278,570
Nov 13, 2023Mack David Henrydirector, officer President and CEOG-GiftBuy85,307--165,307
Nov 13, 2023Mack David Henrydirector, officer President and CEOM-ExemptSell198,407$0.53$105.16K109,459
Sep 18, 2023Jalota Deepikaofficer Chief Development OfficerS-SaleSell4,104$6.62$27.17K29,946
Sep 18, 2023Alland Leilaofficer Chief Medical OfficerS-SaleSell6,291$6.62$41.65K45,909
Aug 08, 2023Mack David Henrydirector, officer President and CEOM-ExemptSell85,500$0.53$45.31K307,866
Aug 08, 2023Mack David Henrydirector, officer President and CEOM-ExemptBuy85,500$0.53$45.31K165,470

The last insider sell of PMV Pharmaceuticals's stock was made by Carulli Michael on Jan 11 2024, selling - shares at - per share (valued at -).

PMV Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 202322100.00%
Q3 20231425.00%
Q2 20231111100.00%
Q4 202221200.00%
Q2 202254125.00%
Q1 202262300.00%
Q4 20212633.33%
Q3 2021158517.65%
Q2 2021268829.55%
Q1 202141723.53%
Q4 202032150.00%
Q3 2020486178.69%

2 total buy trades, and 2 total sell trades (buy/sell ratio of 1.00%) were made by PMV Pharmaceuticals's insiders, as of Q4 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 2023-1-
Q3 2023-2-
Q2 2023---
Q4 2022---
Q2 2022-1-
Q1 2022-1-
Q4 2021-3-
Q3 2021-72-
Q2 2021-74-
Q1 2021-15-
Q4 2020---
Q3 20208--

As of Q4 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of PMV Pharmaceuticals's stocks.

PMV Pharmaceuticals Peer Ownership


TickerCompany
ANEBAnebulo Pharmaceuticals, Inc.
MLYSMineralys Therapeutics, Inc.
PEPGPepGen Inc.
VIGLVigil Neuroscience, Inc.
ELYMEliem Therapeutics, Inc.
TRDAEntrada Therapeutics, Inc.
EWTXEdgewise Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
GLUEMonte Rosa Therapeutics, Inc.
PHVSPharvaris N.V.
RLYBRallybio Corporation
MOLNMolecular Partners AG
MNOVMediciNova, Inc.
OPTOpthea Limited

PMVP Ownership FAQ


PMV Pharmaceuticals is owned by institutional shareholders (83.08%), insiders (2.61%), and public (14.31%). The largest institutional shareholder of PMV Pharmaceuticals is ORBIMED ADVISORS LLC (12.59% of total shares) and the top mutual fund owner is MERIDIAN FUND INC (0.34% of total shares).

PMV Pharmaceuticals's major institutional shareholders are ORBIMED ADVISORS LLC, ARROWMARK COLORADO HOLDINGS LLC, BLACKROCK INC., EUCLIDEAN CAPITAL LLC, and VANGUARD GROUP INC. The top five shareholders own together 34.72% of the company's share outstanding.

As of Mar 2024, there are 100 institutional shareholders of PMV Pharmaceuticals.

ORBIMED ADVISORS LLC owns 6.48M shares of PMV Pharmaceuticals, representing 12.59% of the company's total shares outstanding, valued at $11.01M (as of Mar 2024).

As of Mar 2024, ARROWMARK COLORADO HOLDINGS LLC holds 3.2M shares of PMV Pharmaceuticals (PMVP), compromising 6.22% of the company, valued at $5.44M.

BLACKROCK INC is the third largest holder of PMV Pharmaceuticals. The company owns 3.11M of the company's shares outstanding (worth $5.29M).